{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:41:29Z","timestamp":1793256089328,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T00:00:00Z","timestamp":1448496000000},"content-version":"vor","delay-in-days":1120,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014489","name":"Johnson and Johnson Pharmaceutical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014489","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1038\/jid.2012.184","type":"journal-article","created":{"date-parts":[[2012,7,5]],"date-time":"2012-07-05T07:51:57Z","timestamp":1341474717000},"page":"2552-2564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":272,"title":["Expanding the Psoriasis Disease Profile: Interrogation of the Skin and Serum of Patients with Moderate-to-Severe Psoriasis"],"prefix":"10.1016","volume":"132","author":[{"given":"Mayte","family":"Su\u00e1rez-Fari\u00f1as","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judilyn","family":"Fuentes-Duculan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Brodmerkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2012.184_bb0010","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1046\/j.1365-2133.2003.05287.x","article-title":"Normal keratinocytes express Toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis","volume":"148","author":"Baker","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2012.184_bb0015","first-page":"497","article-title":"Expression, subcellular localization and cytokinic modulation of Toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin","volume":"17","author":"Begon","year":"2007","journal-title":"Eur J Dermatol"},{"key":"10.1038\/jid.2012.184_bb0020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J Royal Stat Soc Ser B"},{"key":"10.1038\/jid.2012.184_bb0025","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/BF00197417","article-title":"Refined mapping of the psoriasin gene S100A7 to chromosome 1cen-q21","volume":"96","author":"Borglum","year":"1995","journal-title":"Hum Genet"},{"key":"10.1038\/jid.2012.184_bb0030","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/jid.2010.340","article-title":"Integrative responses to IL-17 and TNF-alpha in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis","volume":"131","author":"Chiricozzi","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2012.184_bb0035","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2010.103","article-title":"Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions","volume":"130","author":"Davidovici","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2012.184_bb0040","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/jid.2009.319","article-title":"Molecular dissection of psoriasis: integrating genetics and biology","volume":"130","author":"Elder","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2012.184_bb0045","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ng.689","article-title":"Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2","volume":"42","author":"Ellinghaus","year":"2010","journal-title":"Nat Genet"},{"key":"10.1038\/jid.2012.184_bb0050","first-page":"199","article-title":"High prevalence of cardiovascular diseases and enhanced activity of the renin-angiotensin system in psoriatic patients","volume":"40","author":"Ena","year":"1985","journal-title":"Acta Cardiol"},{"key":"10.1038\/jid.2012.184_bb0055","article-title":"SAS System for Linear Models","author":"Freund","year":"1986"},{"key":"10.1038\/jid.2012.184_bb0060","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1038\/jid.2010.165","article-title":"A subpopulation of CD163-positive macrophages is classically activated in psoriasis","volume":"130","author":"Fuentes-Duculan","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2012.184_bb0065","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis","volume":"296","author":"Gelfand","year":"2006","journal-title":"JAMA"},{"key":"10.1038\/jid.2012.184_bb0070","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2174\/138920111798281018","article-title":"Cardiovascular risk and endothelial dysfunction: the preferential route for atherosclerosis","volume":"12","author":"Grassi","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1038\/jid.2012.184_bb0075","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1056\/NEJMoa0810652","article-title":"Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis","volume":"362","author":"Griffiths","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1038\/jid.2012.184_bb0080","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jaad.2007.02.015","article-title":"Analysis of global gene expression and genetic variation in psoriasis","volume":"57","author":"Gudjonsson","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2012.184_bb0085","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/jid.2010.36","article-title":"Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models","volume":"130","author":"Gudjonsson","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2012.184_bb0090","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.4049\/jimmunol.180.3.1913","article-title":"Identification of cellular pathways of \u201ctype 1,\u201d Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasis","volume":"180","author":"Haider","year":"2008","journal-title":"J Immunol"},{"key":"10.1038\/jid.2012.184_bb0095","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/1523-1747.ep12345807","article-title":"Assignment of psoriasin to human chromosomal band 1q21: coordinate overexpression of clustered genes in psoriasis","volume":"106","author":"Hardas","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2012.184_bb0100","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1365-4632.2009.04358.x","article-title":"Is psoriasis a pre-atherosclerotic disease? Increased insulin resistance and impaired endothelial function in patients with psoriasis","volume":"49","author":"Karadag","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1038\/jid.2012.184_bb0105","doi-asserted-by":"crossref","first-page":"19057","DOI":"10.1073\/pnas.0509736102","article-title":"Increase in TNF-alpha and inducible, nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)","volume":"102","author":"Lowes","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2012.184_bb0110","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/1523-1747.ep12340429","article-title":"Evidence for an alternative pathway of keratinocyte maturation in psoriasis from an antigen found in psoriatic but not normal epidermis","volume":"83","author":"Mansbridge","year":"1984","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2012.184_bb0115","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/nbt1239","article-title":"The MicroArray Quality Control (MAQC) project shows inter-and intraplatform reproducibility of gene expression measurements","volume":"24","author":"MAQC ConsortiumShi","year":"2006","journal-title":"Nat Biotech"},{"key":"10.1038\/jid.2012.184_bb0120","series-title":"Multivariate Analysis","author":"Mardia","year":"1979"},{"key":"10.1038\/jid.2012.184_bb0125","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/eurheartj\/ehp567","article-title":"Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database","volume":"31","author":"Mehta","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1038\/jid.2012.184_bb0130","doi-asserted-by":"crossref","first-page":"H1908","DOI":"10.1152\/ajpheart.2001.281.5.H1908","article-title":"eNOS 894T allele and coronary blood flow at rest and during adenosine-induced hyperemia","volume":"281","author":"Naber","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1038\/jid.2012.184_bb0135","first-page":"1092","article-title":"Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways","volume":"159","author":"Nograles","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2012.184_bb0140","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.tpj.6500067","article-title":"Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling","volume":"1","author":"Oestreicher","year":"2001","journal-title":"Pharmacogenomics J"},{"key":"10.1038\/jid.2012.184_bb0145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1752-0509-4-41","article-title":"Integrated network analysis of transcriptomic and proteomic data in psoriasis","volume":"4","author":"Piruzian","year":"2010","journal-title":"BMC Syst Biol"},{"key":"10.1038\/jid.2012.184_bb0150","doi-asserted-by":"crossref","first-page":"e9701","DOI":"10.1371\/journal.pone.0009701","article-title":"Activation of PPARbeta\/delta causes psoriasis-like skin disease in vivo","volume":"16","author":"Romanowska","year":"2010","journal-title":"PLoS One"},{"key":"10.1038\/jid.2012.184_bb0155","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.4049\/jimmunol.0903719","article-title":"8-methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL-23\/Th17 axis and induction of Foxp3+ regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder","volume":"184","author":"Singh","year":"2010","journal-title":"J Immunol"},{"key":"10.1038\/jid.2012.184_bb0160","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ng.693","article-title":"Genome-wide association analysis identifies three psoriasis susceptibility loci","volume":"42","author":"Stuart","year":"2010","journal-title":"Nat Genet"},{"key":"10.1038\/jid.2012.184_bb0165","doi-asserted-by":"crossref","first-page":"e10247","DOI":"10.1371\/journal.pone.0010247","article-title":"Evaluation of the psoriasis transcriptome across different studies by gene set enrichment analysis (GSEA)","volume":"5","author":"Su\u00e1rez Fari\u00f1as","year":"2010","journal-title":"PLoS One"},{"key":"10.1038\/jid.2012.184_bb0170","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-1-59745-390-5_8","article-title":"Comparing microarray studies","volume":"377","author":"Su\u00e1rez Fari\u00f1as","year":"2007","journal-title":"Methods Mol Biol"},{"key":"10.1038\/jid.2012.184_bb0175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1471-2164-6-99","article-title":"Comparing independent microarray studies: the case of human embryonic stem cells","volume":"6","author":"Su\u00e1rez Fari\u00f1as","year":"2005","journal-title":"BMC Genomics"},{"key":"10.1038\/jid.2012.184_bb0180","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/1471-2105-6-294","article-title":"Harshlight: a \u201ccorrective make-up\u201d program for microarray chips","volume":"6","author":"Su\u00e1rez Fari\u00f1as","year":"2005","journal-title":"BMC Bioinform"},{"key":"10.1038\/jid.2012.184_bb0185","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/ng.690","article-title":"Association analyses identify six new psoriasis susceptibility loci in the Chinese population","volume":"42","author":"Sun","year":"2010","journal-title":"Nat Genet"},{"key":"10.1038\/jid.2012.184_bb0190","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1198\/016214504000000683","article-title":"A model based background adjustement for oligonucleotide expression arrays","volume":"99","author":"Wu","year":"2004","journal-title":"J Am Stat Assoc"},{"key":"10.1038\/jid.2012.184_bb0195","doi-asserted-by":"crossref","first-page":"e2737","DOI":"10.1371\/journal.pone.0002737","article-title":"Type I interferon: potential therapeutic target for psoriasis?","volume":"3","author":"Yao","year":"2008","journal-title":"PLoS One"},{"key":"10.1038\/jid.2012.184_bb0200","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.jaci.2010.03.018","article-title":"Identification of TNF-related apoptosis inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis","volume":"125","author":"Zaba","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1038\/jid.2012.184_bb0205","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/ng.310","article-title":"Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21","volume":"41","author":"Zhang","year":"2009","journal-title":"Nat Genet"},{"key":"10.1038\/jid.2012.184_bb0210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1152\/physiolgenomics.00157.2002","article-title":"Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array","volume":"13","author":"Zhou","year":"2003","journal-title":"Physiol Genomics"}],"updated-by":[{"DOI":"10.1038\/jid.2015.220","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000}}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15355032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15355032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T13:41:48Z","timestamp":1743946908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15355032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0022202X15355032"],"URL":"https:\/\/doi.org\/10.1038\/jid.2012.184","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718030688.793480218","asserted-by":"object"}]},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expanding the Psoriasis Disease Profile: Interrogation of the Skin and Serum of Patients with Moderate-to-Severe Psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2012.184","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}